These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Pharmacokinetics of cefodizime in volunteers with normal or impaired renal function. Conte JE J Clin Pharmacol; 1994 Nov; 34(11):1066-70. PubMed ID: 7876397 [TBL] [Abstract][Full Text] [Related]
17. The disposition and protein binding of batanopride and its metabolites in subjects with renal impairment. St Peter JV; Brady ME; Foote EF; Dandekar KA; Smaldone L; Pykkonen JL; Keane WF; Halstenson CE Eur J Clin Pharmacol; 1993; 45(1):59-63. PubMed ID: 8405031 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and hepatic extraction ratio of pindolol in hypertensive patients with normal and impaired renal function. Lavene D; Weiss YA; Safar ME; Loria Y; Agorus N; Georges D; Milliez PL J Clin Pharmacol; 1977; 17(8-9):501-8. PubMed ID: 893736 [TBL] [Abstract][Full Text] [Related]
19. Cefotaxime and desacetyl cefotaxime kinetics in renal impairment. Matzke GR; Abraham PA; Halstenson CE; Keane WF Clin Pharmacol Ther; 1985 Jul; 38(1):31-6. PubMed ID: 4006373 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of metoclopramide intravenously and orally determined by liquid chromatography. Graffner C; Lagerström PO; Lundborg P; Rönn O Br J Clin Pharmacol; 1979 Nov; 8(5):469-74. PubMed ID: 508553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]